Preview

Epidemiology and Vaccinal Prevention

Advanced search

Comparative Assessment of Preventable Socioeconomic Damage in Different Approaches to the Prevention of Vaccine-Controlled Infections in the Framework of the National Vaccination Schedule

https://doi.org/10.31631/2073-3046-2020-19-1-4-13

Abstract

Relevance.The strategy for the development of vaccine prevention in the Russian Federation among other areas involves improving the National schedule of preventive vaccinations and ensuring its flexibility, taking into account the current epidemic situation and the emergence of new vaccines.

Goal: to Assess the socio-economic damage from five vaccine-controlled infections in different vaccine prevention scenarios.

Materials and methods: a simulated retrospective model was constructed with a time horizon of 3 years (2016-2018), which assumes an assessment of changes in lost/ saved years of life including in monetary terms in the context of differentiated disease outcomes and vaccine costs under different scenarios of vaccination coverage and the vaccine prevention algorithm.

Results: if the established algorithm is maintained and the age cohort of children under 2 years of age is covered by vaccination, the annual loss of years of life will remain at a high level. Extending the five-component vaccine coverage to 60% of children in the 3-to 18-month age group will reduce losses to 20,215 years, saving 10,263 years of life (33.7% more than the current algorithm), and even more if coverage is close to 100%: annual losses will decrease to 2,134 years, which can provide 28,344 saved years of life (93% more than the current algorithm). The study showed that the more widely the combined pentavalent vaccine is used, the lower the average cost of saving each additional year of life.

Conclusions. Expanding the coverage of a combination vaccine provides the greatest additional benefits due to a faster increase in the number of saved years of life (benefits) compared to the increase in costs (cost of vaccines).

About the Authors

N. I. Briko
Sechenov University
Russian Federation

Nikolaj I. Briko - academician of the Russian Academy of Sciences, Dr. Sci. (Med.), professor, Director of the Institute of Public Health and Head of the Department of Epidemiology and Evidence-Based Medicine of SU, Author ID-7004344976

B. Pirogovskaya, 2, 2. Moscow, 119435, +7 (499) 248 04 13



L. D. Popovich
Institute for Health Economics of Higher School of Economics
Russian Federation

Larisa D. Popovich - director of Institute of Health Economics.

Moscow, +79261432443



A. Ya. Mindlina
Sechenov University
Russian Federation

Alla Yakovlevna Mindlina - professor of department of epidemiology and evidence-based Medicine of Sechenov University.

2/2 Bolshaya Pirogovskaya str., Moscow, 119435. +7 (916)935-38-51



O. I. Volkova
Institute for Health Economics of Higher School of Economics
Russian Federation

Olga I. Volkova - expert of Institute of Health Economics.

Moscow, +79035254523


E. O. Kurilovich
Institute for Health Economics of Higher School of Economics
Russian Federation

Ekaterina O. Kurilovich - expert of Institute of Health Economics.

Moscow, +79629421561


References

1. Briko NI, Feldblyum IV. The modern concept of development of vaccine prevention in Russia. Epidemiology and Vaccinal Prevention. 2019; 19 (5): 4 - 13 (In Russ.).

2. Namazova-Baranova LS, Fedoseenko MV, Baranov AA. New horizons of the National calendar of preventive vaccinations. Issues of modern pediatrics. 2019; 18 (1): 13 - 30 (In Russ.).

3. World Health Organization. Global Immunization Vision and Strategy. Available at: www.who.int/vaccines-documents/DocsPDF05/GIVS_Final_EN.pdf.

4. World Health Organization. More than 140,000 die from measles as cases surge worldwide. Available at: https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide.

5. On the verge of an epidemic. Why measles, diphtheria and whooping cough returned to Ukraine [article]. Focus (daily news Internet resource) Available at: https://focus.ua/ukraine/413141-na-konchike-igly (In Russ.).

6. Diphtheria in Russia in the 21st century. Epidemiology and Vaccinal Prevention. 2017; 5:4 - 14 (In Russ.).

7. Maman K1, Zollner Y, Greco D at al. The value of childhood combination vaccines: From beliefs to evidence. Human Vaccines & Immunotherapeutics. 2015; 11 (9): 21322214.

8. Harit SM, Briko NI. Actual problems of vaccine prevention and methods for their solutions: the experience of the expert council on public health of the Federation Council Committee on Social Policy. Medical Technologies. Rating and selection. 2014; 3:32-36.

9. Ozawa S, Por tnoy A, Getaneh H.,et al., Modeling the economic burden of adult vaccine-preventable diseases in the united states. Health Affairs, 2016.

10. Draft departmental act of the Ministry of Health of Russia «On the approval of the national calendar of preventive vaccinations, the calendar of preventive vaccinations according to epidemic indications and the procedure for conducting preventive vaccinations». Available at: https://regulation.gov.ru/projects#npa=95954.

11. Order of the M inistry of Healthcare of the Russian Federation, March 21,2014 No. 125n «On approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations according to epidemic indications».

12. Mikheeva IV, Akimova YuI, Mikheeva MA. Application of the five-component vaccine AaMDT-IPV-Hib within the national calendar of preventive vaccinations. Pediatric pharmacology. 2019; 16 (3): 171-179.

13. Murray CJ, Vos T, Lozano R at al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859).

14. Foreman KJ, Marquez N, Dolgert A at al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for2016 - 40 for 195 countries and territories//Lancet. 2018; 392:2052-2090.

15. Prokhorov BB., Shmakov D.I. Estimation of the cost of statistical life and economic damage from health losses. Studies on Russian Economic Development. 2002;3:125-135.

16. State report «On the state of the sanitary-epidemiological well-being of the population in the Russian Federation in 2018». Rospotrebnadzor. 2019.

17. Platonov AE, Nikolaev MK, Koroleva IS et al. A prospective population-based study of the incidence of purulent meningitis in children under 5 years of age in 8 cities of Russia. Epidemiology and Infectious Diseases. 2009; 4:133-143.

18. Methodological recommendations. MR3.3.1.0001-10 «Epidemiology and vaccine prophylaxis of infection caused by Haemophilus influenzae type b». A pproved by the Chief State Sanitary Doctor of the Russian Federation 03/31/2010.

19. Clinical recommendations of the Ministry of Healthcare of the Russian Federation. Community-acquired pneumonia, 2018.

20. Clinical recommendations for the vaccination of hemophilic type b infection in children, Ministry of Healthcare of the Russian Federation, Union of Pediatricians of Russia. 2016.

21. Information on infectious and parasitic diseases for January - December 2018. Rospotrebnadzor, Federal Center for Hygiene and Epidemiology. Available at: https://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=11277.

22. Materials of the Coordination Center for the Prevention of Poliomyelitis and Enterovirus (Non-Polio) Infections «Key Qualitative Indicators of Epidemiological Surveillance for POLIO/OPV in the Russian Federation (January - August 2019)». Newsletter «Epidemiological Surveillance for POLIO/OPV in the Subjects of the Russian Federation». 2019. Available at: https://www.fcgie.ru/page,7,koord_tsentr.htmi (accessedJuly30,2019).

23. Harit SM, Pokrovsky VS, Ruleva AA, Fridman IV. WHO polio eradication program: problems and solutions. Pediatricheskaya Farmakologiya. 2016; 1 (3): 289-298.

24. Interdisciplinary meeting of experts «Unresolved issues of the epidemiology of whooping cough in the Russian Federation and new opportunities for its vaccine prevention». Epidemiology and Vaccinal Prevention. 2018; 17 (4): 63-67.

25. Decker M., Bogaerts H., Edwards K. Combination vaccines. In: Vaccines. 5th edition. Plotkin S. A., Orenstein W., Offit P. A. (Eds). USA, Saunders Co., PA. 2008. Р 1069-1101.

26. Pichichero M. E. New combination vaccines. Pediatr. Clin. North. Am. 2000; 47 (2): 407-426.

27. Suetina IG, Illek YYu., Khlebnikova NV et al. The problem of timely vaccination of young children and ways to solve it. Epidemiology and Vaccinal Prevention. 2019; 19 (5): 85-89.

28. Haemophilus influenzae type b (Hib) Vaccination Position Paper.WHO. Weekly epidemiological record. 2013; 88 (39): 413-28.

29. 29. Harit SM, Iosefovich OV, Ruleva AA et al. Safety and reactogenicity assessment of the Pentaxim combination vaccine. Epidemiology and infectious diseases. Actual issues. 2017; 2:62-66.


Review

For citations:


Briko N.I., Popovich L.D., Mindlina A.Ya., Volkova O.I., Kurilovich E.O. Comparative Assessment of Preventable Socioeconomic Damage in Different Approaches to the Prevention of Vaccine-Controlled Infections in the Framework of the National Vaccination Schedule. Epidemiology and Vaccinal Prevention. 2020;19(1):4-13. (In Russ.) https://doi.org/10.31631/2073-3046-2020-19-1-4-13

Views: 1467


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)